{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:35:15Z","timestamp":1791174915137,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PON 01_00110"],"award-info":[{"award-number":["PON 01_00110"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN-2009BM7LJC"],"award-info":[{"award-number":["PRIN-2009BM7LJC"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.ijpharm.2012.10.014","type":"journal-article","created":{"date-parts":[[2012,10,15]],"date-time":"2012-10-15T21:46:35Z","timestamp":1350337595000},"page":"135-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["Polymeric nanoparticles augment the ocular hypotensive effect of melatonin in rabbits"],"prefix":"10.1016","volume":"440","author":[{"given":"Teresa","family":"Musumeci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Bucolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Pignatello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Drago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Puglisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2012.10.014_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-079X.2010.00816.x","article-title":"The role of melatonin in glaucoma: implications concerning pathophysiological relevance and therapeutic potential","volume":"50","author":"Agorastos","year":"2011","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.ijpharm.2012.10.014_bib0010","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1124\/jpet.110.178319","article-title":"Design of novel melatonin analogs for the reduction of intraocular pressure in normotensive rabbits","volume":"337","author":"Alarma-Estrany","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijpharm.2012.10.014_bib0130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neulet.2011.02.056","article-title":"Removal of melatonin receptor type 1 increases intraocular pressure and retinal ganglion cells death in the mouse","volume":"494","author":"Alcantara-Contreras","year":"2011","journal-title":"Neurosci Lett."},{"key":"10.1016\/j.ijpharm.2012.10.014_bib0015","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.exer.2008.11.004","article-title":"Ophtalmic formulations of the intraocular hypotensive melatonin agent 5-MCA-NAT","volume":"88","author":"Andr\u00e9s-Guerrero","year":"2009","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ijpharm.2012.10.014_bib0020","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1167\/iovs.10-6099","article-title":"The use of mucoadhesive polymers to enhance the hypotensive effect of a melatonin analog (5-MCA-NAT) in rabbit eyes","volume":"52","author":"Andr\u00e9s-Guerrero","year":"2011","journal-title":"Inv. Ophthalm. Visual Sci."},{"key":"10.1016\/j.ijpharm.2012.10.014_bib0025","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijpharm.2008.07.004","article-title":"Freeze drying of human serum albumin (HSA) nanoparticles with different excipients","volume":"363","author":"Anhorn","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.10.014_bib0030","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1211\/0022357023835","article-title":"Eudragit RL100 nanoparticle system for the ophthalmic delivery of cloricromene","volume":"56","author":"Bucolo","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2012.10.014_bib0035","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1600-079X.2011.00938.x","article-title":"Involvement of carbonic anhydrases in the ocular hypotensive effect of melatonin analogue 5-MCA-NAT","volume":"52","author":"Crooke","year":"2012","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.ijpharm.2012.10.014_bib0135","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: an overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.10.014_bib0045","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.nano.2009.09.002","article-title":"Design of Eudragit RL 100 nanoparticles by nanoprecipitation method for ocular drug delivery","volume":"6","author":"Das","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijpharm.2012.10.014_bib0050","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1517\/17425247.2011.542142","article-title":"Ocular drug delivery \u2013 a look towards nanobioadhesives","volume":"8","author":"Du Toit","year":"2011","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2012.10.014_bib0055","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1023\/A:1023290514575","article-title":"Influence of preparations on acyclovir-loaded poly-d,l-lactic acid nanospheres and effect of PEG coating on ocular drug bioavailability","volume":"20","author":"Giannavola","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.10.014_bib0060","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1208\/s12249-009-9236-z","article-title":"Effect of sugars, surfactant, and tangential flow filtration on the freeze-drying","volume":"10","author":"Hirsj\u00e4rvi","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2012.10.014_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v28.i1.10","article-title":"Engineered PLGA nanoparticles: an emerging delivery tool in cancer therapeutics","volume":"28","author":"Jain","year":"2011","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.ijpharm.2012.10.014_bib0070","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12325-011-0003-7","article-title":"Polyquad-preserved travoprost\/timolol, benzalkonium chloride (BAK)-preserved travoprost\/timolol, and latanoprost\/timolol in fixed combinations: a rabbit ocular surface study","volume":"28","author":"Liang","year":"2011","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ijpharm.2012.10.014_bib0075","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.addr.2005.07.005","article-title":"The use of mucoadhesive polymers in ocular drug delivery","volume":"57","author":"Ludwig","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2012.10.014_bib0080","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijpharm.2011.04.031","article-title":"Chitosan\/sulfobutylether-beta-cyclodextrin nanoparticles as a potential approach for ocular drug delivery","volume":"413","author":"Mahmoud","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.10.014_bib0085","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.autneu.2008.12.009","article-title":"New treatments for ocular hypertension","volume":"147","author":"Mediero","year":"2009","journal-title":"Auton. Neurosci. Basic Clin."},{"key":"10.1016\/j.ijpharm.2012.10.014_bib0090","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijpharm.2006.06.023","article-title":"PLA\/PLGA nanoparticles for sustained release of docetaxel","volume":"325","author":"Musumeci","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.10.014_bib0095","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1166\/jnn.2006.452","article-title":"Lyoprotected nanosphere formulations for paclitaxel controlled delivery","volume":"6","author":"Musumeci","year":"2006","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.ijpharm.2012.10.014_bib0100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/1877912311101010042","article-title":"Nanotechnology in ophthalmic drug delivery: a survey of recent developments and patenting activity","volume":"1","author":"Pignatello","year":"2011","journal-title":"Recent Pat. Nanomed."},{"key":"10.1016\/j.ijpharm.2012.10.014_bib0105","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0014-2999(01)00864-0","article-title":"Involvement of melatonin MT(3) receptors in the regulation of intraocular pressure in rabbits","volume":"416","author":"Pintor","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijpharm.2012.10.014_bib0110","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/sj.bjp.0705118","article-title":"Ocular hypotensive effects of melatonin receptor agonists in the rabbit: further evidence for an MT3 receptor","volume":"138","author":"Pintor","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ijpharm.2012.10.014_bib0115","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3109\/02713688809033192","article-title":"Effect of melatonin on intraocular pressure","volume":"7","author":"Samples","year":"1988","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ijpharm.2012.10.014_bib0120","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/01.ijg.0000133150.44686.0b","article-title":"Effect of 5-MCA-NAT, a putative melatonin MT3 receptor agonist, on intraocular pressure in glaucomatous monkey eyes","volume":"13","author":"Serle","year":"2004","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.ijpharm.2012.10.014_bib0125","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s11095-008-9800-3","article-title":"Methods for the preparation and manufacture of polymeric nanoparticles","volume":"26","author":"Vauthier","year":"2009","journal-title":"Pharm. Res."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312009544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312009544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:28:13Z","timestamp":1759915693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517312009544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0378517312009544"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2012.10.014","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymeric nanoparticles augment the ocular hypotensive effect of melatonin in rabbits","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2012.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}